Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 1863 entries
View as:

Study of Romiplostim for Chemotherapy Induced Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT02052882 Org: User:
Start: 01/30/14 End: 11/13/23 Due: 11/13/24

Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support

Phase: N/A Priority: Normal
NCT ID: NCT02701829 Org: User:
Start: 02/29/16 End: 02/28/26 Due: 02/28/27

Clinical Trial of Phenformin in Combination With BRAF Inhibitor + MEK Inhibitor for Patients With BRAF-mutated Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03026517 Org: User:
Start: 01/31/17 End: 01/21/25 Due: 01/21/26

Treatment With Intravitreal Avastin for Large Uveal Melanomas

Phase: N/A Priority: Normal
NCT ID: NCT00596362 Org: User:
Start: 04/30/07 End: 06/30/08 Due: 06/30/09

Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003105 Org: User:
Start: 09/30/97 End: 08/31/04 Due: 08/31/05

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Phase: N/A Priority: Normal
NCT ID: NCT01916135 Org: User:
Start: 07/31/13 End: 04/23/20 Due: 04/23/21

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT03434730 Org: User:
Start: 02/07/18 End: 04/18/25 Due: 04/18/26

Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00058396 Org: User:
Start: 10/31/02 End: - Due: -

Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity

Phase: N/A Priority: Normal
NCT ID: NCT03342586 Org: User:
Start: 11/07/17 End: 08/04/22 Due: 08/04/23

Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training

Phase: N/A Priority: Normal
NCT ID: NCT02726763 Org: User:
Start: 03/30/16 End: 03/31/26 Due: 03/31/27

Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004925 Org: User:
Start: 08/31/99 End: 08/31/03 Due: 08/31/04

Genomic Predictors of Papillary Microcarcinoma Disease Progression

Phase: N/A Priority: Normal
NCT ID: NCT02363595 Org: User:
Start: 12/31/14 End: 12/31/25 Due: 12/31/26

An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04837833 Org: User:
Start: 04/06/21 End: 04/06/26 Due: 04/06/27

Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00410956 Org: User:
Start: 05/09/07 End: 05/07/24 Due: 05/07/25

A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06699602 Org: User:
Start: 02/11/25 End: 02/29/28 Due: 02/28/29

Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00606216 Org: User:
Start: 01/31/07 End: 12/31/15 Due: 12/31/16

Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04435444 Org: User:
Start: 06/15/20 End: 06/30/25 Due: 06/30/26

COBRA: Cancer, Older Adults, Balance and Resistance Activities

Phase: N/A Priority: Normal
NCT ID: NCT07011862 Org: User:
Start: 05/30/25 End: 05/30/27 Due: 05/30/28

Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase: N/A Priority: Normal
NCT ID: NCT03030885 Org: User:
Start: 01/19/17 End: 04/02/19 Due: 04/02/20

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05053230 Org: User:
Start: 09/20/21 End: 09/20/25 Due: 09/20/26

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT01815359 Org: User:
Start: 03/31/13 End: 09/30/26 Due: 09/30/27

Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02282358 Org: User:
Start: 10/31/14 End: 05/26/23 Due: 05/26/24

A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor

Phase: N/A Priority: Normal
NCT ID: NCT05275426 Org: User:
Start: 03/02/22 End: 03/02/26 Due: 03/02/27

A Study of the EMPOWER Program for Latinx Caregivers of ICU Patients

Phase: N/A Priority: Normal
NCT ID: NCT05589883 Org: User:
Start: 10/18/22 End: 11/07/23 Due: 11/07/24

Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00858663 Org: User:
Start: 03/31/09 End: 07/31/13 Due: 07/31/14